Big Changes in Blood Pressure: A Simple Guide to the 2025 Hypertension Guidelines
The new 2025 AHA/ACC guidelines introduce significant, evidence-based updates to hypertension management. Here is what every pharmacist needs to know.
Jimmy Pruitt, PharmD, BCPS, BCCCP
Emergency Medicine Clinical Pharmacy Specialist
Introduction
The way doctors and pharmacists manage high blood pressure is about to change. The new 2025 AHA/ACC Hypertension Guidelines have been released, introducing significant, evidence-based updates designed to improve patient safety and provide more effective care.
Whether you are a patient or a healthcare provider, it’s important to understand these key shifts. Here’s a simple breakdown of what you need to know.
What’s Covered
- 1 “Hypertensive Urgency” gets a new name and a safer approach
- 2 A smarter way to decide who needs medication: the PREVENT Calculator
- 3 New rules for stroke and brain bleeds
- 4 Critical updates for managing hypertension in pregnancy
“Hypertensive Urgency” Gets a New Name and a Safer Approach
One of the biggest changes is the terminology. The term “hypertensive urgency” is now being replaced with “severe hypertension.” This refers to a blood pressure reading higher than 180/120 mm Hg in a patient without symptoms of acute target organ damage.
Key Definition
Severe hypertension = BP > 180/120 mm Hg without symptoms of acute target organ damage. This replaces the older term “hypertensive urgency.”
Why the change? The old term often led to unnecessary emergency department visits and the use of potent IV medications that could lower blood pressure too quickly, causing harm. The new approach for patients with asymptomatic severe hypertension is to:
- Avoid IV medications in the hospital or ED.
- Start well-tolerated oral medications instead.
- Arrange for a follow-up appointment with a primary care provider or cardiologist within a few days.
Important
Rapidly lowering blood pressure with IV medications in asymptomatic severe hypertension can be harmful. The new guidelines emphasize a measured, oral-medication-first approach with close outpatient follow-up.
A Smarter Way to Decide Who Needs Medication: The PREVENT Calculator
The new guidelines integrate the PREVENT risk calculator, a more accurate and inclusive tool for predicting a person’s 10-year risk of heart attack or stroke. This calculator includes factors like kidney disease and social determinants of health to better guide treatment decisions.
PREVENT Risk Calculator
The PREVENT calculator is a more inclusive 10-year cardiovascular risk prediction tool that factors in kidney disease and social determinants of health, replacing the older Pooled Cohort Equations.
The new rules are:
High-Risk Patients
If you have established cardiovascular disease, diabetes, chronic kidney disease, or a PREVENT risk score of 7.5% or higher, medication is now recommended if your blood pressure is 130/80 mm Hg or higher.
Lower-Risk Patients
If your blood pressure is between 130-139/80-89 mm Hg and your risk score is less than 7.5%, the first step is a 3-6 month trial of lifestyle changes. Medication is only recommended if blood pressure remains high after that period.
Clinical Pearl
The PREVENT calculator is more inclusive than the older Pooled Cohort Equations. It accounts for kidney function and social determinants of health, making it a better tool for diverse patient populations.
New Rules for Stroke and Brain Bleeds
The guidelines provide critical updates for managing blood pressure during neurological emergencies:
After an Ischemic Stroke (Post-Reperfusion)
The guidelines now state that lowering systolic blood pressure below 140 mm Hg in the first 24-72 hours can be harmful and should be avoided. The goal is to maintain pressure between 140-180 mm Hg to ensure the brain gets enough blood flow to recover.
Target Range
SBP 140-180 mm Hg in the first 24-72 hours post-reperfusion. Avoid lowering below 140 mm Hg.
For a Brain Bleed (ICH)
If the systolic pressure is between 150-220 mm Hg, the new target is to lower it to 130-140 mm Hg within the first 7 days.
For extremely high pressures (>220 mm Hg), a continuous IV infusion is recommended over single “bolus” injections to prevent dangerous blood pressure swings.
ICH Targets
SBP 150-220 mm Hg: target 130-140 mm Hg within 7 days. SBP >220 mm Hg: use continuous IV infusion (avoid bolus dosing).
Important
In post-reperfusion ischemic stroke, aggressive blood pressure lowering below 140 mm Hg can compromise cerebral perfusion and worsen outcomes. Always target the recommended range.
Critical Updates for Managing Hypertension in Pregnancy
The 2025 guidelines emphasize safer and more proactive care for pregnant patients:
-
Treat Urgently
Severe hypertension (BP ≥160/110 mm Hg) during pregnancy is a medical emergency. Treatment must be started within 30-60 minutes to prevent a maternal stroke.
-
Treat Earlier
For chronic hypertension in pregnancy, treatment should now begin when blood pressure is 140-159/90-109 mm Hg to a target of <140/90 mm Hg.
-
Preeclampsia Prevention
Low-dose aspirin (81 mg daily) is strongly recommended for pregnant patients with chronic hypertension, starting at 12 weeks of gestation, to reduce the risk of preeclampsia.
-
Medication Safety
The list of contraindicated medications has been expanded. Common drugs like ACE inhibitors (e.g., lisinopril), ARBs (e.g., losartan), and the beta-blocker atenolol should be avoided during pregnancy due to risks to the fetus.
Treatment Threshold
Severe hypertension in pregnancy (BP ≥160/110 mm Hg) requires treatment initiation within 30-60 minutes. For chronic hypertension, initiate treatment at 140-159/90-109 mm Hg with a target of <140/90 mm Hg.
Contraindicated in Pregnancy
ACE inhibitors (e.g., lisinopril), ARBs (e.g., losartan), and atenolol are all contraindicated. Always verify medication safety before prescribing to pregnant patients.
Guideline Resources
These updates represent a major step forward in hypertension management. For healthcare professionals seeking more information, the following resources are available:
Conclusion
Key Takeaway
The 2025 AHA/ACC Hypertension Guidelines shift toward safer terminology, individualized risk-based treatment with the PREVENT calculator, nuanced stroke management, and more proactive pregnancy care.
The 2025 AHA/ACC guidelines represent a paradigm shift in hypertension management. By replacing “hypertensive urgency” with “severe hypertension,” the guidelines discourage aggressive and potentially harmful interventions for asymptomatic patients. The introduction of the PREVENT calculator provides a more inclusive and accurate framework for determining who needs pharmacotherapy.
For neurological emergencies, the new BP targets reflect a deeper understanding of cerebral perfusion needs. And for pregnant patients, earlier treatment thresholds and clear medication safety guidance will help prevent maternal and fetal complications.
As pharmacists, staying current with these changes is essential for providing safe, evidence-based care. Use the resources linked above to deepen your understanding and incorporate these updates into your clinical practice.
Written By
Jimmy Pruitt, PharmD, BCPS, BCCCP
Emergency Medicine Clinical Pharmacy Specialist
Dr. Pruitt is a board-certified pharmacotherapy specialist and board-certified critical care pharmacist practicing in emergency medicine. He is dedicated to advancing pharmacy education and clinical excellence through evidence-based content at PACU.
Level Up Your Practice
Ready to advance your pharmacy career?
Join thousands of pharmacy professionals learning with PACU. Start your free trial today.